Quantity:   

Travellers’ Diarrhoea (TD) is the number one health problem in international travel in terms of frequency and economic impact, affecting up to half of travellers to high-risk areas such as Africa, Asia and South America.

Anadis has developed a natural biopharmaceutical medicine that actually reduces the risk of Travellers’ Diarrhoea (TD). The product, called Travelan (AUST L 106709), contains a natural product obtained from dairy cows. Travelan has undergone medical clinical trials in the US and Europe and has shown up to 90% protection against the bacteria that causes Travellers' Diarrhoea, enterotoxigenic E. coli (ETEC).

Travelan reduces your risk of getting TD rather than having to treat the symptoms after the condition has begun. Travelan has been shown in medical clinical trials to significantly decrease the risk of TD and to decrease the symptoms of minor gastrointestinal disorders.

It is estimated that up to 40% of the world's millions of travellers succumb to TD from ETEC infection (through food and drink) each year. The current treatment is to take an anti-spasmodic following symptoms of infection (diarrhoea, nausea & cramps) or, in severe cases, antibiotics. Travelan however, transfers antibodies to boost a body’s immunity to the bacteria that cause TD.